Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 10.58B | 10.58B | 10.24B | 9.28B | 8.31B | 7.52B |
Gross Profit | 5.22B | 5.22B | 5.05B | 4.68B | 4.58B | 4.57B |
EBITDA | 2.39B | 2.97B | 2.69B | 2.24B | 1.99B | 2.15B |
Net Income | 1.18B | 1.18B | 1.17B | 962.76M | 943.56M | 1.24B |
Balance Sheet | ||||||
Total Assets | 11.09B | 11.09B | 9.56B | 8.22B | 7.39B | 6.25B |
Cash, Cash Equivalents and Short-Term Investments | 1.73B | 1.73B | 1.90B | 1.44B | 979.40M | 1.45B |
Total Debt | 0.00 | 0.00 | 314.55M | 314.55M | 514.55M | 17.15M |
Total Liabilities | 2.57B | 2.57B | 2.22B | 2.03B | 2.14B | 1.89B |
Stockholders Equity | 8.43B | 8.43B | 7.25B | 6.10B | 5.16B | 4.26B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 471.81M | 449.70M | 759.49M | -468.96M | 500.63M |
Operating Cash Flow | 0.00 | 2.11B | 1.97B | 2.31B | 698.24M | 1.32B |
Investing Cash Flow | 0.00 | -1.97B | -1.50B | -1.65B | -1.67B | -1.15B |
Financing Cash Flow | 0.00 | -312.95M | 825.00K | -199.91M | 493.74M | 620.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
67 Neutral | ¥23.54B | 17.81 | 2.22% | 17.22% | 10.53% | ||
66 Neutral | ¥28.00B | 20.66 | 3.29% | 7.42% | -4.90% | ||
66 Neutral | ¥31.14B | 26.00 | ― | 4.86% | 7.22% | ||
65 Neutral | ¥18.77B | 32.94 | 0.90% | 22.72% | 71.04% | ||
64 Neutral | ¥28.68B | 27.17 | ― | 23.85% | 138.81% | ||
61 Neutral | $35.48B | 7.63 | -10.11% | 1.88% | 8.73% | -9.23% | |
― | ¥16.44B | 31.73 | ― | ― | ― |
OPTiM Corporation has confirmed its compliance with the Tokyo Stock Exchange’s listing maintenance criteria for the Prime Market by increasing its ratio of tradable shares to 35.4% as of March 2025. This compliance was achieved after the company’s major shareholder sold a portion of shares, aligning with their plan to maintain listing standards and enhance corporate value.
OPTiM Corp. reported a decrease in financial performance for the nine months ended December 31, 2024, with net sales declining by 3.1% and significant drops in operating and ordinary profits compared to the same period in the previous year. This decline may impact the company’s market positioning and stakeholder confidence, as the company navigates through financial challenges without any changes in accounting policies or forecasts.